Viewpoint Dispatches from the Frontlines of Research-edited by John W. Nelson

摘要

The American Diabetes Association has determined that diabetes costs the United States more than Dollars 170 billion per year in associated health care costs (1). Even more discouraging is the fact that the percentage of individuals diagnosed with type II diabetes continues to climb both in the U.S. and worldwide. Although numerous medications are prescribed to treat hyperglycemia, finding effective treatments for diabetes and the resulting microvascular-related complications remains a challenge. Thus discovery of new modalities by which to treat this condition is of the utmost importance.